Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin A receptor

被引:59
|
作者
Giragossian, C
Mierke, DF [1 ]
机构
[1] Brown Univ, Dept Mol Pharmacol, Div Biol & Med, Providence, RI 02912 USA
[2] Brown Univ, Dept Chem, Providence, RI 02912 USA
关键词
D O I
10.1021/bi002659n
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of the C-terminal octapeptide of cholecystokinin, CCK-8, with the third extracellular loop of human cholecystokinin-A receptor, CCKA-R(329-357), has been probed by high-resolution NMR and extensive computer simulations. The structure of CCKA-R(329-357) in the presence of dodecylphosphocholine micelles consists of three alpha -helices, with the first and third corresponding to the extracellular ends of transmembrane (TM) helices 6 and 7. The central helix, residues W335-R345, is found to lie on the zwitterionic surface. Titration with CCK-8 produces a stable complex with a number of intermolecular NOEs between the C-terminus of the Ligand (Trp(30), Met(31), Asp(32)) and the interface of TM6 and the third extracellular loop (N333, A334, Y338) of the receptor fragment. The mode of ligand binding based on these intermolecular NOEs is in agreement with a number of published findings from receptor mutagenesis and photoaffinity cross-linking Utilizing these ligand/receptor points of interaction, the structural features of CCKA-R(329-357), and also the structures of CCK-8 and CCKA-R(1-47) previously determined, extensive molecular dynamics simulations of the CCK-81CCK(A)-R complex were carried out. The results provide unique insight into the molecular interactions and forces important for the binding of CCK-8 to CCKA-R.
引用
收藏
页码:3804 / 3809
页数:6
相关论文
共 50 条
  • [41] Time course of intranasally administered cholecystokinin-8 on central nervous effects
    Pietrowsky, R
    Claassen, L
    Frercks, H
    Fehm, HL
    Born, J
    NEUROPSYCHOBIOLOGY, 2001, 43 (04) : 254 - 259
  • [42] Canine vagus nerve stores cholecystokinin-58 and-8 but releases only cholecystokinin-8 upon electrical vagal stimulation
    Chang, TM
    Thagesen, H
    Lee, KY
    Roth, FL
    Chey, WY
    REGULATORY PEPTIDES, 2000, 87 (1-3) : 1 - 7
  • [43] BRAIN CHOLECYSTOKININ-8 IMMUNOREACTIVITY IN RATS WITH EXPERIMENTAL LIVER-CIRRHOSIS
    SALERNO, F
    BONATO, C
    PANERAI, AE
    MARTINI, A
    MALESCI, A
    LIFE SCIENCES, 1983, 33 (04) : 377 - 381
  • [44] Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor (vol 31, pg 1381, 2013)
    Da Costa, Gregory
    Bondon, Arnaud
    Coutant, Jerome
    Curmi, Patrick
    Monti, Jean-Pierre
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2014, 32 (01): : 170 - 170
  • [45] CAROTID LIGATION ALTERS CHOLECYSTOKININ-8 (CCK-8) IMMUNOREACTIVITY IN GERBIL BRAINS
    XU, C
    YANG, CL
    DU, XL
    WEI, Q
    LI, C
    PEPTIDES, 1986, 7 (06) : 973 - 976
  • [46] INSULINOTROPIC PROPERTIES OF SYNTHETIC HUMAN GASTRIC-INHIBITORY POLYPEPTIDE IN MAN - INTERACTIONS WITH GLUCOSE, PHENYLALANINE, AND CHOLECYSTOKININ-8
    NAUCK, M
    SCHMIDT, WE
    EBERT, R
    STRIETZEL, J
    CANTOR, P
    HOFFMANN, G
    CREUTZFELDT, W
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (03): : 654 - 662
  • [47] INTERACTION OF CHOLECYSTOKININ-8 AND PANCREATIC GLUCAGON IN CONTROL OF FOOD-INTAKE IN DOGS
    KALOGERIS, TJ
    REIDELBERGER, RD
    MENDEL, VE
    SOLOMON, TE
    AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (04): : R688 - R692
  • [48] INTRACEREBROVENTRICULAR CHOLECYSTOKININ-8 ELEVATES PLASMA PANCREATIC-POLYPEPTIDE IN AWAKE DOGS
    GREELEY, G
    LU, QH
    ZHU, XG
    THOMPSON, JC
    GASTROENTEROLOGY, 1983, 84 (05) : 1174 - 1174
  • [49] Plasma cholecystokinin-8 in pigs with divergent genetic potential for feed intake and growth
    Clutter, AC
    Jiang, R
    McCann, JP
    Buchanan, DS
    DOMESTIC ANIMAL ENDOCRINOLOGY, 1998, 15 (01) : 9 - 21
  • [50] Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs
    Ninomiya, K
    Saito, T
    Wakatsuki, K
    Saeki, M
    Kato, T
    Kasai, H
    Kimura, K
    Fujii, M
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1998, 48 (01): : 52 - 54